Exosens joins the SBF 120 index

Barely a year after its successful IPO on Euronext, Exosens will be included in the SBF 120 index from 24 March before market opening. This new step, which will enable the Group to increase its liquidity on the financial markets and its attractiveness to investors, is in line with a robust growth trajectory driven by its capacity for innovation, its leadership in critical defense technologies, and its diversification into the Life Sciences, Industrial Control and Nuclear sectors. Congratulations to Jérôme Cerisier and all his teams around the world.